PB 36 of 2022

National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2022 (No. 4)

I, CAROLINE TURNOUR, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, and delegate of the Minister for Health and Aged Care, make the following determination.

Dated   28 April 2022

CAROLINE TURNOUR

Contents

1 Name…………………………………………………………………………….………………1

2 Commencement

3 Authority

4  Schedule

Schedule 1—Amendments 2

National Health (Continued Dispensing - Emergency Measures) Determination 2020 2

1 Name

(1)           This instrument is the National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2022 (No. 4).

(2)           This instrument may also be cited as PB 36 of 2022.

2 Commencement

(1)           Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)           Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3 Authority

This instrument is made under subsection 89A(3) of the National Health Act 1953.

4 Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Continued Dispensing – Emergency Measures) Determination 2020

[1]           Schedule 1, after entry for Anastrozole

 insert:

[2]           Schedule 1, after entry for Budesonide in the form Rectal foam 2 mg per application, 14 applications, aerosol 16.8 g, 2

 insert:

[3]           Schedule 1, entry for Desmopressin

omit:

[4]           Schedule 1, after entry for Triglycerides ‑ medium chain, formula in the form Oral liquid 500 mL, 8 (Nutrini Peptisorb)

insert:

[5]           Schedule 1, after entry for Varenicline in the form Tablet 1 mg (as tartrate)

insert: